News About: Pharm. Industry


Drug firms pin hopes on passage of OTC drug sales bill

Many drug makers are keeping a watch on the movement of lawmakers as the government’s plan to allow the sale of painkillers and cold medicines at convenience stores is being screened at the parliamentary committee. ...

LG Life Sciences veers into generic drug markets with Pfizer

LG Life Sciences said Tuesday that it has forged a strategic alliance with Pfizer Vitals in an effort to promote its generic business at home and abroad. Under the deal, LG will be in charge of developing and produ...

Tylenol price to rise

Johnson & Johnson Korea has a plan to increase the prices of all Tylenol products regardless of ethical or OTC, according to Janssen Korea. It is expected that Tylenol prices will increase by 10 to 20 percent soon...

KPMA splits over president’s nomination

A controversy is quietly brewing within the Korea Pharmaceutical Manufacturers Association ahead of its next president’s nomination on the board of directors meeting on Feb. 16. The key member of KPMA leadership te...

‘Xalost’ ophthalmic agent goes to 17 European countries

Xalost (latanoprost) eye drop, a glaucoma drug, will be exported to 17 European countries, Taejoon Pharma announced on Monday. Taejoon has recently received the marketing authorization for Xalost in Switzerland and...

100 billion won offered as drug rebates over 5 years

Korean drug makers have been discovered to offer nearly 100 billion won in rebates between 2006 and 2010, an antitrust regulator said Sunday. In 2011 alone, 17 local and multinational firms were ordered to pay 14.3...

Handok, Genexine to join forces in co-development of new drugs

Handok Pharmaceutical and Genexine Co., a drug development biotech, agreed to join hands to develop biobetters and biodrugs so that they can stay competitive with its foreign rivals. The two companies signed a memo...

Daewoong, Almirall enter into licensing agreement for new COPD treatment

Daewoong Pharmaceutical said Thursday that it has signed an exclusive licensing agreement with Spain based Almirall S.A. for marketing Amirall’s Eklira (aclidinium bromide) in Korea. Aclidinium bromide is a novel, ...

1,606 new product licenses issued in 2011

The Korea Food and Drug Administration announced Thursday that except for oriental medicines, licenses for new products totaled 1,606, a decrease of 25 percent a year earlier. Of the licenses, prescription drugs ac...

Winners of the 13th Korea New Drug Award

The Korea Drug Research Association, under the sponsorship of the Ministry of Health and Welfare, Ministry of Knowledge Economy and the Ministry of Education, Science and Technology, will award two Korean companies wi...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.